Posts

Showing posts with the label Licensing

Translate

Partnerships, Licensing, Investments and M&A Deals and Trends for November 2016 in Pharmaceuticals

Image
Albany, New York, Feb 09, 2017 "Partnerships, Licensing, Investments and M&A Deals and Trends for November 2016 in Pharmaceuticals" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. Description- GlobalData's Partnerships, Licensing, Investments and M&A Deals and Trends for November 2016 in Pharmaceuticals report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in November 2016. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report p

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q3 Pharmaceutical 2016

Image
"Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q3 2016" The Report covers current Market Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. Description- GlobalData's Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q3 2016 report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in Q3 2016. The report portrays detailed comparative data on the number of deals and their value in the last five quarters, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in

Partnerships, Licensing, Investments and M&A Deals and Trends for September 2016 in Pharmaceuticals

"Partnerships, Licensing, Investments and M&A Deals and Trends for September 2016 in Pharmaceuticals" The Report covers current Market Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. Description- Licensing, Investments and M&A Deals and Trends for September 2016 in Pharmaceuticals report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in September 2016. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pha